Alexander vaiserman
Alexander vaiserman
Head of the Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine
Verified email at geront.kiev.ua
Title
Cited by
Cited by
Year
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population
A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ...
BMC microbiology 17 (1), 1-6, 2017
2582017
Gut microbiota: a player in aging and a target for anti-aging intervention
AM Vaiserman, AK Koliada, F Marotta
Ageing research reviews 35, 36-45, 2017
1322017
Epigenetic programming by early‐life stress: Evidence from human populations
AM Vaiserman
Developmental Dynamics 244 (3), 254-265, 2015
1112015
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment
AM Vaiserman
Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010
1102010
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study
LH Lumey, MD Khalangot, AM Vaiserman
The lancet Diabetes & endocrinology 3 (10), 787-794, 2015
932015
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge?
A Vaiserman
Aging and disease 5 (6), 419, 2014
862014
Early-life nutritional programming of longevity
AM Vaiserman
Journal of developmental origins of health and disease 5 (5), 325-338, 2014
762014
Hormesis and epigenetics: is there a link?
AM Vaiserman
Ageing research reviews 10 (4), 413-421, 2011
762011
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine
AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ...
Diabetologia 50 (1), 32-35, 2007
702007
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?
A Vaiserman
Clinical epigenetics 7 (1), 96, 2015
672015
Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity
AM Vaiserman
Dose-Response 8 (1), dose-response. 09-014. Vaiserman, 2010
632010
Anti-aging pharmacology: promises and pitfalls
AM Vaiserman, V Lushchak, AK Koliada
Ageing research reviews 31, 9-35, 2016
622016
Early-life origin of adult disease: evidence from natural experiments
A Vaiserman
Experimental Gerontology 46 (2-3), 189-192, 2011
422011
Effects of X-irradiation in early ontogenesis on the longevity and amount of the S1 nuclease-sensitive DNA sites in adult Drosophila melanogaster
AM Vaiserman, NM Koshel, AY Litoshenko, TG Mozzhukhina, ...
Biogerontology 4 (1), 9-14, 2003
402003
Seasonal programming of adult longevity in Ukraine
A Vaiserman, A Collinson, N Koshel, I Belaja, V Voitenko
International Journal of Biometeorology 47 (1), 49-52, 2002
392002
Epigenetic drugs: a novel anti-aging strategy?
A Vaiserman, EG Pasyukova
Frontiers in genetics 3, 224, 2012
382012
HDAC inhibitors: A new promising drug class in anti-aging research
EG Pasyukova, AM Vaiserman
Mechanisms of ageing and development 166, 6-15, 2017
372017
Fucoxanthin and lipid metabolism: A minireview
K Muradian, A Vaiserman, KJ Min, VE Fraifeld
Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015
372015
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives
A Vaiserman, O Lushchak
Journal of translational medicine 15 (1), 160, 2017
352017
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues
A Vaiserman, A Koliada, O Zabuga, Y Socol
Dose-Response 16 (3), 1559325818796331, 2018
342018
The system can't perform the operation now. Try again later.
Articles 1–20